{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:16:42Z","timestamp":1783055802907,"version":"3.54.6"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Oskar Huttunen Foundation"},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["O7R-1888"],"award-info":[{"award-number":["O7R-1888"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mental health disorders cause substantial patient suffering, which could be alleviated through early diagnostic biomarkers. While biomarker discovery is costly, genetic methods utilizing data from large-scale studies, such as Mendelian randomization, may provide a cost-effective approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-sample Mendelian randomization analysis was conducted to identify potential urinary biomarkers of seven psychiatric disorders using summary statistics from GWAS data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis revealed 67 analyte-disorder associations, of which 21 were exclusive to a single disorder. Notable associations were observed between tyrosine and schizophrenia (\u03b2 = -0.041, SE\u2009=\u20090.013, Q\u2009=\u20090.027), creatine and bipolar disorder (\u03b2 = -0.077, SE\u2009=\u20090.019, Q\u2009=\u20090.002), pyridoxal (\u03b2\u2009=\u20090.10, SE\u2009=\u20090.03, Q\u2009=\u20090.042) and ferulic acid 4-sulfate (\u03b2 = \u20090.077, SE\u2009=\u20090.025, Q\u2009=\u20090.037) to anorexia nervosa, and N, N-dimethylglycine to ADHD (\u03b2 = -0.39, SE\u2009=\u20090.11, Q\u2009=\u20090.008).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results identify candidate urinary biomarkers and demonstrate the utility of genetic instruments for biomarker discovery, warranting experimental validation in independent cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08133-7","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:14:29Z","timestamp":1778170469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of urinary metabolite biomarkers of psychiatric disorders using two-sample Mendelian randomization"],"prefix":"10.1186","volume":"26","author":[{"given":"Jihan K.","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade A.","family":"McCune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren A.","family":"Scherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"8133_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"A Ferrari","year":"2022","unstructured":"Ferrari A, Santomauro D, Mantilla Herrera A, Shadid J, Ashbaugh C, Erskine H, et al. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry"},{"key":"8133_CR2","unstructured":"Department of Health. Annual report of the chief medical officer 2013 public mental health priorities: investing in the evidence. 2014."},{"key":"8133_CR3","unstructured":"Mccrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S. Paying the price: the cost of mental health care in England in 2026. Kings Fund. 2008;:15\u201334."},{"key":"8133_CR4","doi-asserted-by":"publisher","first-page":"e2351","DOI":"10.1002\/brb3.2351","volume":"11","author":"J Simon","year":"2021","unstructured":"Simon J, Pari AAA, Wolstenholme J, Berger M, Goodwin GM, Geddes JR. The costs of bipolar disorder in the United Kingdom. Brain Behav. 2021;11:e2351.","journal-title":"Brain Behav"},{"key":"8133_CR5","first-page":"23","volume":"10","author":"R Mangalore","year":"2007","unstructured":"Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ. 2007;10:23\u201341.","journal-title":"J Ment Health Policy Econ"},{"key":"8133_CR6","doi-asserted-by":"crossref","unstructured":"Hung CI, Liu CY, Yang CH. Untreated duration predicted the severity of depression at the two-year follow-up point. PLoS ONE. 2017;12.","DOI":"10.1371\/journal.pone.0185119"},{"key":"8133_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1176\/appi.ajp.2017.17090972","volume":"175","author":"E Vieta","year":"2018","unstructured":"Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, et al. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175:411\u201326.","journal-title":"Am J Psychiatry"},{"key":"8133_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1176\/appi.ajp.2019.19080865","volume":"176","author":"JA Lieberman","year":"2019","unstructured":"Lieberman JA, Small SA, Girgis RR. Early detection and preventive intervention in schizophrenia: from fantasy to reality. Am J Psychiatry. 2019;176:794\u2013810.","journal-title":"Am J Psychiatry"},{"key":"8133_CR9","doi-asserted-by":"publisher","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. 2010;167:748\u201351. https:\/\/doi.org\/10.1176\/appi.ajp.2010.09091379.","DOI":"10.1176\/appi.ajp.2010.09091379"},{"key":"8133_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000228838","volume":"42","author":"E Cheniaux","year":"2009","unstructured":"Cheniaux E, Landeira-Fernandez J, Versiani M. The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10. Psychopathology. 2009;42:293\u20138.","journal-title":"Psychopathology"},{"key":"8133_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.tics.2019.03.009","volume":"23","author":"E Feczko","year":"2019","unstructured":"Feczko E, Miranda-Dominguez O, Marr M, Graham AM, Nigg JT, Fair DA. The heterogeneity problem: approaches to identify psychiatric subtypes. Trends Cogn Sci. 2019;23:584\u2013601.","journal-title":"Trends Cogn Sci"},{"key":"8133_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-021-00333-7","volume":"20","author":"G Ayano","year":"2021","unstructured":"Ayano G, Demelash S, yohannes Z, Haile K, Tulu M, Assefa D, et al. Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia. Ann Gen Psychiatry. 2021;20:1\u201310.","journal-title":"Ann Gen Psychiatry"},{"key":"8133_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-2483-y","volume":"20","author":"\u00c1 Lubl\u00f3y","year":"2020","unstructured":"Lubl\u00f3y \u00c1, Kereszt\u00fari JL, N\u00e9meth A, Mihalicza P. Exploring factors of diagnostic delay for patients with bipolar disorder: a population-based cohort study. BMC Psychiatry. 2020;20:1\u201317.","journal-title":"BMC Psychiatry"},{"key":"8133_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1017\/S0033291703001119","volume":"34","author":"RMG Norman","year":"2004","unstructured":"Norman RMG, Malla AK, Verdi MB, Hassall LD, Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychol Med. 2004;34:255\u201366.","journal-title":"Psychol Med"},{"key":"8133_CR15","doi-asserted-by":"publisher","unstructured":"Harpole M, Davis J, Espina V. Current state of the art for enhancing urine biomarker discovery. 2016;13:609\u201326. https:\/\/doi.org\/10.1080\/14789450.2016.1190651.","DOI":"10.1080\/14789450.2016.1190651"},{"key":"8133_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-94-017-9523-4_9","volume":"845","author":"Y Chen","year":"2015","unstructured":"Chen Y. Variations of human urinary proteome. Adv Exp Med Biol. 2015;845:91\u20134.","journal-title":"Adv Exp Med Biol"},{"key":"8133_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/pr100835s","volume":"10","author":"N Nagaraj","year":"2011","unstructured":"Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res. 2011;10:637\u201345.","journal-title":"J Proteome Res"},{"key":"8133_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:601.","journal-title":"BMJ"},{"key":"8133_CR19","doi-asserted-by":"crossref","unstructured":"K Zaki J, Tomasik J, McCune J, Scherman O, Bahn S. Meta-analysis of urinary metabolite GWAS studies identifies three novel genome-wide significant loci. bioRxiv. 2024;2024.06.25.600593.","DOI":"10.1101\/2024.06.25.600593"},{"key":"8133_CR20","doi-asserted-by":"publisher","first-page":"e1005487","DOI":"10.1371\/journal.pgen.1005487","volume":"11","author":"J Raffler","year":"2015","unstructured":"Raffler J, Friedrich N, Arnold M, Kacprowski T, Rueedi R, Altmaier E, et al. Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality. PLoS Genet. 2015;11:e1005487.","journal-title":"PLoS Genet"},{"key":"8133_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41588-019-0567-8","volume":"52","author":"P Schlosser","year":"2020","unstructured":"Schlosser P, Li Y, Sekula P, Raffler J, Grundner-Culemann F, Pietzner M, et al. Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans. Nat Genet. 2020;52:167\u201376.","journal-title":"Nat Genet"},{"key":"8133_CR22","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pgen.1002270","volume":"7","author":"G Nicholson","year":"2011","unstructured":"Nicholson G, Rantalainen M, Li JV, Maher AD, Malmodin D, Ahmadi KR, et al. A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet. 2011;7:e1002270.","journal-title":"PLoS Genet"},{"key":"8133_CR23","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1093\/hmg\/ddaa257","volume":"29","author":"B Calvo-Serra","year":"2021","unstructured":"Calvo-Serra B, Maitre L, Lau CHE, Siskos AP, G\u00fctzkow KB, Andru\u0161aityt\u0117 S, et al. Urinary metabolite quantitative trait loci in children and their interaction with dietary factors. Hum Mol Genet. 2021;29:3830\u201344.","journal-title":"Hum Mol Genet"},{"key":"8133_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","volume":"53","author":"N Sinnott-Armstrong","year":"2021","unstructured":"Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M, et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021;53:185\u201394.","journal-title":"Nat Genet"},{"key":"8133_CR25","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190\u20131.","journal-title":"Bioinformatics"},{"key":"8133_CR26","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1681\/ASN.2017101099","volume":"29","author":"Y Li","year":"2018","unstructured":"Li Y, Sekula P, Wuttke M, Wahrheit J, Hausknecht B, Schultheiss UT, et al. Genome-wide association studies of metabolites in patients with CKD identify multiple loci and illuminate tubular transport mechanisms. J Am Soc Nephrol. 2018;29:1513\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"8133_CR27","doi-asserted-by":"publisher","first-page":"e1004132","DOI":"10.1371\/journal.pgen.1004132","volume":"10","author":"R Rueedi","year":"2014","unstructured":"Rueedi R, Ledda M, Nicholls AW, Salek RM, Marques-Vidal P, Morya E, et al. Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links. PLoS Genet. 2014;10:e1004132.","journal-title":"PLoS Genet"},{"key":"8133_CR28","doi-asserted-by":"crossref","unstructured":"Sekula P, Tin A, Schultheiss UT, Baid-Agrawal S, Mohney RP, Steinbrenner I et al. Urine 6-Bromotryptophan: associations with genetic variants and incident end-stage kidney disease. Sci Rep. 2020;10:1\u201311.","DOI":"10.1038\/s41598-020-66334-w"},{"key":"8133_CR29","doi-asserted-by":"publisher","first-page":"e51954","DOI":"10.1371\/journal.pone.0051954","volume":"7","author":"AG Comuzzie","year":"2012","unstructured":"Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA, et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the hispanic population. PLoS ONE. 2012;7:e51954.","journal-title":"PLoS ONE"},{"key":"8133_CR30","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1681\/ASN.2013070781","volume":"25","author":"M Olden","year":"2014","unstructured":"Olden M, Corre T, Hayward C, Toniolo D, Ulivi S, Gasparini P, et al. Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. J Am Soc Nephrol. 2014;25:1869\u201382.","journal-title":"J Am Soc Nephrol"},{"key":"8133_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"D Demontis","year":"2018","unstructured":"Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder. Nat Genet. 2018;51:63\u201375.","journal-title":"Nat Genet"},{"key":"8133_CR32","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41588-019-0439-2","volume":"51","author":"HJ Watson","year":"2019","unstructured":"Watson HJ, Yilmaz Z, Thornton LM, H\u00fcbel C, Coleman JRI, Gaspar HA, et al. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019;51:1207\u201314.","journal-title":"Nat Genet"},{"key":"8133_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431\u201344.","journal-title":"Nat Genet"},{"key":"8133_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","volume":"53","author":"N Mullins","year":"2021","unstructured":"Mullins N, Forstner AJ, O\u2019Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817\u201329.","journal-title":"Nat Genet"},{"key":"8133_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","volume":"50","author":"NR Wray","year":"2018","unstructured":"Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668\u201381.","journal-title":"Nat Genet"},{"key":"8133_CR36","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"8133_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","volume":"176","author":"D Yu","year":"2019","unstructured":"Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, et al. Interrogating the genetic determinants of Tourette\u2019s syndrome and other tiC disorders through genome-wide association studies. Am J Psychiatry. 2019;176:217\u201327.","journal-title":"Am J Psychiatry"},{"key":"8133_CR38","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"key":"8133_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"8133_CR40","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3557.","journal-title":"Bioinformatics"},{"key":"8133_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf\u00f2 MR, et al. Mendelian randomization. Nat Reviews Methods Primers. 2022;2:6.","journal-title":"Nat Reviews Methods Primers"},{"key":"8133_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"8133_CR43","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations. Bioinformatics. 2019;35:4851\u20133.","journal-title":"Bioinformatics"},{"key":"8133_CR44","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et al. PhenoScanner: a database of human genotype\u2013phenotype associations. Bioinformatics. 2016;32:3207\u20139.","journal-title":"Bioinformatics"},{"key":"8133_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.euroneuro.2005.06.003","volume":"16","author":"R Hoekstra","year":"2006","unstructured":"Hoekstra R, Fekkes D, Loonen AJM, Pepplinkhuizen L, Tuinier S, Verhoeven WMA. Bipolar mania and plasma amino acids: increased levels of glycine. Eur Neuropsychopharmacol. 2006;16:71\u20137.","journal-title":"Eur Neuropsychopharmacol"},{"key":"8133_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neubiorev.2014.08.017","volume":"47","author":"M Ghasemi","year":"2014","unstructured":"Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neurosci Biobehav Rev. 2014;47:336\u201358.","journal-title":"Neurosci Biobehav Rev"},{"key":"8133_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107\u2013213.","journal-title":"Physiol Rev"},{"key":"8133_CR48","doi-asserted-by":"crossref","unstructured":"Kious BM, Kondo DG, Renshaw PF. Creatine for the treatment of depression. Biomolecules. 2019;9:406.","DOI":"10.3390\/biom9090406"},{"key":"8133_CR49","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.neubiorev.2012.03.005","volume":"36","author":"PJ Allen","year":"2012","unstructured":"Allen PJ. Creatine metabolism and psychiatric disorders: does creatine supplementation have therapeutic value? Neurosci Biobehav Rev. 2012;36:1442\u201362.","journal-title":"Neurosci Biobehav Rev"},{"key":"8133_CR50","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 2004;61:450\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"8133_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00702-017-1817-5","volume":"125","author":"RA Toniolo","year":"2018","unstructured":"Toniolo RA, Silva M, Fernandes F, de BF, Amaral JA, de MS, Dias RdaS, Lafer B. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression. J Neural Transm. 2018;125:247\u201357.","journal-title":"J Neural Transm"},{"key":"8133_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1399-0004.2010.01457.x","volume":"79","author":"A Drousiotou","year":"2011","unstructured":"Drousiotou A, DiMeo I, Mineri R, Georgiou T, Stylianidou G, Tiranti V. Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches. Clin Genet. 2011;79:385\u201390.","journal-title":"Clin Genet"},{"key":"8133_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01583-z","volume":"4","author":"DJ Panyard","year":"2021","unstructured":"Panyard DJ, Kim KM, Darst BF, Deming YK, Zhong X, Wu Y, et al. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations. Commun Biol. 2021;4:1\u201311.","journal-title":"Commun Biol"},{"key":"8133_CR54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mam.2011.10.008","volume":"32","author":"C Indiveri","year":"2011","unstructured":"Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, et al. The mitochondrial carnitine\/acylcarnitine carrier: function, structure and physiopathology. Mol Aspects Med. 2011;32:223\u201333.","journal-title":"Mol Aspects Med"},{"key":"8133_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10061202","volume":"10","author":"A K\u0119pka","year":"2021","unstructured":"K\u0119pka A, Ochoci\u0144ska A, Chojnowska S, Borzym-Kluczyk M, Skorupa E, Kna\u015b M, et al. Potential role of L-Carnitine in autism spectrum disorder. J Clin Med. 2021;10:1\u201326.","journal-title":"J Clin Med"},{"key":"8133_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.schres.2017.05.003","volume":"187","author":"KH Flippo","year":"2017","unstructured":"Flippo KH, Strack S. An emerging role for mitochondrial dynamics in schizophrenia. Schizophr Res. 2017;187:26\u201332.","journal-title":"Schizophr Res"},{"key":"8133_CR57","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang J-J, Griffin JL, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004;9:684\u201397.","journal-title":"Mol Psychiatry"},{"key":"8133_CR58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"JT Coyle","year":"1996","unstructured":"Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3:241\u201353.","journal-title":"Harv Rev Psychiatry"},{"key":"8133_CR59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III\u2014the final common pathway. Schizophr Bull. 2009;35:549\u201362.","journal-title":"Schizophr Bull"},{"key":"8133_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys. 2011;508:12.","journal-title":"Arch Biochem Biophys"},{"key":"8133_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00002826-199402000-00006","volume":"17","author":"SI Deutsch","year":"1994","unstructured":"Deutsch SI, Rosse RB, Schwartz BL, Banay-Schwartz M, McCarthy MF, Johri SK. L-tyrosine pharmacotherapy of schizophrenia: preliminary data. Clin Neuropharmacol. 1994;17:53\u201362.","journal-title":"Clin Neuropharmacol"},{"key":"8133_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0920-9964(99)00029-8","volume":"40","author":"FA Wiesel","year":"1999","unstructured":"Wiesel FA, Andersson JLR, Westerberg G, Wieselgren IM, Bjerkenstedt L, Hagenfeldt L, et al. Tyrosine transport is regulated differently in patients with schizophrenia. Schizophr Res. 1999;40:37\u201342.","journal-title":"Schizophr Res"},{"key":"8133_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1017\/S1461145705005638","volume":"9","author":"L Bjerkenstedt","year":"2006","unstructured":"Bjerkenstedt L, Farde L, Terenius L, Edman G, Venizelos N, Wiesel FA. Support for limited brain availability of tyrosine in patients with schizophrenia. Int J Neuropsychopharmacol. 2006;9:247\u201355.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8133_CR64","doi-asserted-by":"publisher","first-page":"29826","DOI":"10.1074\/jbc.M110.152629","volume":"285","author":"F Collard","year":"2010","unstructured":"Collard F, Stroobant V, Lamosa P, Kapanda CN, Lambert DM, Muccioli GG, et al. Molecular identification of N-Acetylaspartylglutamate synthase and \u03b2-Citrylglutamate synthase. J Biol Chem. 2010;285:29826\u201333.","journal-title":"J Biol Chem"},{"key":"8133_CR65","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.1038\/s41598-019-46109-8","volume":"9","author":"J Lopez-Castroman","year":"2019","unstructured":"Lopez-Castroman J, Leiva-Murillo JM, Cegla-Schvartzman F, Blasco-Fontecilla H, Garcia-Nieto R, Artes-Rodriguez A, et al. Onset of schizophrenia diagnoses in a large clinical cohort. Sci Rep. 2019;9:9865.","journal-title":"Sci Rep"},{"key":"8133_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0165-0327(98)00032-9","volume":"50","author":"A Gonzalez-Pinto","year":"1998","unstructured":"Gonzalez-Pinto A, Gutierrez M, Mosquera F, Ballesteros J, Lopez P, Ezcurra J, et al. First episode in bipolar disorder: misdiagnosis and psychotic symptoms. J Affect Disord. 1998;50:41\u20134.","journal-title":"J Affect Disord"},{"key":"8133_CR67","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/schbul\/sbz138","volume":"46","author":"J Yang","year":"2020","unstructured":"Yang J, Yan B, Zhao B, Fan Y, He X, Yang L, et al. Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders. Schizophr Bull. 2020;46:804\u201313.","journal-title":"Schizophr Bull"},{"key":"8133_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2022.08.015","volume":"93","author":"T Lu","year":"2023","unstructured":"Lu T, Forgetta V, Greenwood CMT, Zhou S, Richards JB. Circulating proteins influencing psychiatric disease: a Mendelian randomization study. Biol Psychiatry. 2023;93:82\u201391.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08133-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08133-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:23:24Z","timestamp":1783052604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08133-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8133"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08133-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Tomasik has a patent pending for dried blood spot biomarkers for bipolar disorder. Dr Bahn reported grants from Stanley Medical Research Institute and Psyomics during the conduct of the study; is a founder and shareholder in Psyomics; is Director of Psynova Neurotech outside the submitted work; and has a patent pending for dried blood spot biomarkers for bipolar disorder. The other authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}